Follow Wally on Twitter at: @wmwitkowski.On Jan. 20, just nine days after Chinese health authorities published the DNA sequence for a new coronavirus that was causing concern in China, Dr. Michael Osterholm, an epidemiologist at the University of Minnesota, wrote in an email: “I’m certain this will cause our next pandemic.” QRVO: Qorvo Inc Detailed Estimate. Export data to Excel for your own analysis.Qorvo has received a consensus rating of Buy. QRVO reported first-quarter fiscal 2021 non-GAAP earnings of $1.50 per share, which improved 10.3% on a year-over-year basis. Morningstar: © 2019 Morningstar, Inc. All Rights Reserved. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Shares of QRVO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.The P/E ratio of Qorvo is 45.27, which means that it is trading at a more expensive P/E ratio than the Computer and Technology sector average P/E ratio of about 39.46.Qorvo has a PEG Ratio of 2.33. Get the latest Detailed Estimate from Zacks Investment Research. As of March 30, 2020, the former fund manager was holding 3398783 shares of worth $274.04 Million or 2.97% of the total outstanding shares.
Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value. Qorvo trading at 11.8% below its fair value, Earnings are forecast to grow 33% per year, Earnings grew by 495% over the past year.
The company lessened -0.45% of value to its shares in past 6 months, showing an annual growth rate of -12.01% while that of industry is 3.2.
Factset: FactSet Research Systems Inc.2019. Qorvo's stock was trading at $89.42 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Number of shares sold short was 2.24 Million shares which calculate 1.57 days to cover the short interests.20 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of $730.17 Million for the same. The average price target is $124.47 with a high forecast of $160.00 and a low forecast of $105.00. The number of shares represents firm’s hold over 8.62% of outstanding shares, having a total worth of $795.72 Million.Statistics highlight that Qorvo, Inc. is scoring comparatively lower than the scores of other players of the relevant industry.
The company issued revenue guidance of $925-955 million, compared to the consensus revenue estimate of $799.42 million.Identify stocks that meet your criteria using seven unique stock screeners. 9 suggested the stock as a Hold whereas 13 see the stock as a Buy.
Market indices are shown in real time, except for the DJIA, which is delayed by two minutes.
The average price target represents a 11.21% increase from the last price of $111.92. The company is estimating its revenue growth to decline by -16.9% in the current quarter and calculating -5.3% decline in the next quarter. Qorvo stock price target cut to $120 from $135 at Raymond James Apr.
He previously reported for trade publications in covering the drug and medical-device industries back to 1998. Qorvo, Inc quote is equal to 113.980 USD at 2020-07-20. Wall Street analysts have assigned a consensus price target of $121.75 to the stock, which implies a rise of 3.05% to its current value. The company is expected to be making an EPS of $1.13 in the current quarter. Wallace Witkowski came to MarketWatch from the Associated Press in New York, where he was a business reporter specializing in pharmaceutical companies.
And 20 analysts are in estimates of company making revenue of $802.77 Million in the next quarter that will end in September 01, 2020.Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -2.5% during past 5 years. 29. QRVO Stock Analysis Overview .
Your current $100 investment may … Most stock quote data provided by BATS.
QRVO Stock Forecast and Technical Analysis Buy or Hold candidate since 2020-05-14 Gain 8.66% PDF Qorvo fell by -1.47% in the last day (Friday, 26th Jun 2020) from $108.97 to $107.37 During the day the stock fluctuated 2.52% from a day low at $106.69 to a day high of $109.38. Disclaimer. The semiconductor company earns $334.33 million in net income (profit) each year or $5.71 on an earnings per share basis. During the last year, QRVO exceeded the US Semiconductor industry by 22%. The company provided EPS guidance of approx $1.90 for the period, compared to the Thomson Reuters consensus estimate of $1.43. Based on 17 analysts offering 12 month price targets for Qorvo in the last 3 months. Qorvo last released its earnings data on May 7th, 2020. And as of March 30, 2020, it was holding 11.89% of the company’s outstanding shares.On the other hand, Vanguard Total Stock Market Index Fund and Vanguard Mid-Cap Index Fund are the top two Mutual Funds which own company’s shares. "You have already added five stocks to your watchlist.